First-quarter sales from continuing operations of $3.59 billion increased 2% on a reported basis and 3% on a constant currency basis, exceeding the company’s previously issued.
/PRNewswire/ Long Grove Pharmaceuticals continues to meet the critical care needs of hospital pharmacies with the launch of Premix Vasopressin in its most.
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U S pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas
Products feature ready-to-use.